Evidence map›Paper›PMID 37934603›Full record

ArticleInternational journal of epidemiology2024

Time-varying treatment effect modification of oral analgesic effectiveness by depressive symptoms in knee osteoarthritis: an application of structural nested mean models in a prospective cohort.

Alan M Rathbun, Michelle D Shardell, Joseph J Gallo, Alice S Ryan, Elizabeth A Stuart, Megan S Schuler, Yu Dong, Brock Beamer, Rhea Mehta, Jason E Peer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alan M RathbunDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Michelle D ShardellDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5283-2082
Joseph J GalloDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Alice S RyanDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Elizabeth A StuartDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Megan S SchulerRAND Corporation, Arlington, VA, USA.
Yu DongDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Brock BeamerDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Rhea MehtaDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Jason E PeerDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Marc C HochbergDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · USJohns Hopkins University · USRAND Corporation · US

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI Stephen L. Seliger · 2006 to 2026
$28.9M
Statistical methods for vitamin D targets for functional outcomes in older adultsR01AG048069 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2015 to 2025
$4.3M
Methods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical DisabilityR01AG079854 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2023 to 2025
$2.3M
Statistical Models and Mechanisms Linking Biomarkers of Aging to Cognitive-Physical Decline and DementiaRF1NS128360 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2022 to 2022
$2.2M
Causal mediation methods for studying mechanisms in mental healthR01MH115487 · NIMH · JOHNS HOPKINS UNIVERSITY · PI STUART, ELIZABETH A. · 2018 to 2021
$1.3M
A Feasibility and Pilot Study of Combined Treatment Protocol using Aerobic Exercise and Duloxetine in Older Adults with Symptomatic Knee Osteoarthritis and Comorbid DepressionK01AG064041 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI RATHBUN, ALAN MICHAEL · 2019 to 2023
$619k
Epidemiology of the Inverse Comorbidity of Dementia and Cancer: Statistical Methods and Biological MechanismsR03AG070178 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2021 to 2021
$309k
RR&D Research Career Scientist Award ApplicationIK6RX003977 · VA · BALTIMORE VA MEDICAL CENTER · PI ALICE S. RYAN · 2022 to 2026
–
NIA NIH HHS K01 AG064041NIA NIH HHS P30 AG028747NIA NIH HHS R01 AG048069NIA NIH HHS R01 AG079854NIA NIH HHS R03 AG070178NIMH NIH HHS R01 MH115487NINDS NIH HHS RF1 NS128360RRD VA IK6 RX003977
6 · The paper itself

Abstract

backgroundDepressive symptoms are common in knee osteoarthritis (OA), exacerbate knee pain severity and may influence outcomes of oral analgesic treatments. The aim was to assess whether oral analgesic effectiveness in knee OA varies by fluctuations in depressive symptoms.

methodsThe sample included Osteoarthritis Initiative (OAI) participants not treated with oral analgesics at enrolment (n = 1477), with radiographic disease at the first follow-up visit (defined as the index date). Oral analgesic treatment and depressive symptoms, assessed with the Center for Epidemiological Studies Depression [(CES-D) score ≥16] Scale, were measured over three annual visits. Knee pain severity was measured at visits adjacent to treatment and modifier using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale (rescaled range = 0-100). Structural nested mean models (SNMMs) estimated causal mean differences in knee pain severity comparing treatment versus no treatment.

resultsThe average causal effects of treated versus not treated for observations without depressive symptoms showed negligible differences in knee pain severity. However, causal mean differences in knee pain severity comparing treatment versus no treatment among observations with depressive symptoms increased over time from -0.10 [95% confidence interval (CI): -9.94, 9.74] to -16.67 (95% CI: -26.33, -7.01). Accordingly, the difference in average causal effects regarding oral analgesic treatment for knee pain severity between person-time with and without depressive symptoms was largest (-16.53; 95% CI: -26.75, -6.31) at the last time point. Cumulative treatment for 2 or 3 years did not yield larger causal mean differences.

conclusionsKnee OA patients with persistent depressive symptoms and chronic pain may derive more analgesic treatment benefit than those without depressive symptoms and less pain.

Indexed as

Osteoarthritis, KneeAnalgesicsDepressionDisease ProgressionHumansPainProspective StudiesAnalgesicsdepressionKnee osteoarthritispainpharmacoepidemiology

Identifiers

PMID37934603
PMCPMC11491649
OpenAlexW4388446642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.